Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, ...
Nyxoah's disrupting Genio implant is likely to revolutionize Obstructive Sleep Apnea, and FDA's decision is expected in Q1 ...
Leerink Partners analyst Mike Kratky has maintained their neutral stance on INSP stock, giving a Hold rating on December 9.Don't Miss Our ...
Shares of ResMed and Inspire Medical Systems fell after the FDA approved Eli Lilly's weight-loss drug Zepbound to treat ...
In a report released on December 17, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Inspire Medical Systems (INSP – Research ...
Spring-based Texas Sinus & Snoring (346-413-9313) announces an innovative new treatment for obstructive sleep apnea, ...
Worried about how much sleep you're getting or how well you’re sleeping? The best sleep trackers can help you keep track of your sleep patterns, giving you insights to boost your health ...
This new product launch is anticipated to be a major catalyst for growth, potentially strengthening Inspire Medical Systems' competitive position in the sleep apnea treatment market. Analysts view ...
During Boller's operation, surgeons made a 6cm incision below her chin to attach the implant to the nerves that make the ...